| DESCRIPTION | - ALETAHA, ARTHRITIS RHEUM., (2005), vol. 52, no. 9, pages 2625 - 36 | - |
| DESCRIPTION | - ALETAHA D; SMOLEN J, CLIN.EXP.RHEUMATOL, (2005), vol. 23, no. 5, pages S100 - S108 | - |
| DESCRIPTION | - ALTSHUL ET AL., J. MOL. BIOL., (1990), vol. 215, page 403 410 | - |
| DESCRIPTION | - BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 426 | - |
| DESCRIPTION | - BOEHNCKE; MENTER, AM J CLIN DERMATOL, (2013), vol. 14, pages 377 - 88 | - |
| DESCRIPTION | - CLEGG ET AL., ARTHRITIS RHEUM, (1996), vol. 39, pages 2013 - 20 | - |
| DESCRIPTION | - E. MEYERS; W. MILLER, CABIOS, (1989), vol. 4, pages 11 - 17 | - |
| DESCRIPTION | - FAGERLI ET AL., ANN RHEUM DIS, (2013), vol. 72, pages 1840 - 4 | - |
| DESCRIPTION | - FELDMAN; KRUEGER, ANN. RHEUM. DIS., (2005), vol. 64, pages II65 - II68 | - |
| DESCRIPTION | - FELSON ET AL., ARTHRITIS RHEUM, (1995), vol. 38, pages 727 - 35 | - |
| DESCRIPTION | - FRIES ET AL., ARTHRITIS RHEUM, (1980), vol. 23, pages 137 - 45 | - |
| DESCRIPTION | - GLADMAN DD, CURR RHEUMATOL REP, (2007), vol. 9, pages 455 - 60 | - |
| DESCRIPTION | - GLADMAN ET AL., ANN RHEUM DIS., (2005), vol. 64, no. 2, pages II14 - 17 | - |
| DESCRIPTION | - GLADMAN ET AL., ANN RHEUM DIS., (2005), vol. 64, no. 2, pages IIL4 - 17 | - |
| DESCRIPTION | - GOSSEC ET AL., ANN RHEUM DIS, (2012), vol. 71, pages 4 - 12 | - |
| DESCRIPTION | - GOULABCHAND ET AL., ANN RHEUM DIS, (2014), vol. 73, pages 414 - 9 | - |
| DESCRIPTION | - HELLIWELL ET AL., J RHEUMATOL, (2005), vol. 32, pages 1745 - 50 | - |
| DESCRIPTION | - HEUFT- DORENBOSCH L ET AL., ANN RHEUM DIS, (2003), vol. 62, pages 127 - 32 | - |
| DESCRIPTION | - HUSTON ET AL., PROC. NATL. ACAD. SCI., (1988), vol. 85, pages 5879 - 5883 | - |
| DESCRIPTION | - HWANG ET AL., ARTHRITIS RES THER, (2004), vol. 6, pages R120 - 128 | - |
| DESCRIPTION | - JANDUS, ARTHRITIS RHEUM, (2008), vol. 58, pages 2307 - 17 | - |
| DESCRIPTION | - KABAT E.A. ET AL., Sequences of Proteins of Immunological Interest, NATIONAL INSTITUTE OF HEALTH | - |
| DESCRIPTION | - KAGAMI, J INVEST DERMATOL, (2010), vol. 130, pages 1373 - 83 | - |
| DESCRIPTION | - KAVANAUGH ET AL., ANN. RHEUM. DIS., (2014), vol. 73, pages 1000 - 1006 | - |
| DESCRIPTION | - LIN, J IMMUNOL, (2011), vol. 187, pages 490 - 500 | - |
| DESCRIPTION | - MAKSYMOWYCH ET AL., J. RHEUMATOLOGY, (2003), vol. 30, pages 1356 - 63 | - |
| DESCRIPTION | - MCINNES ET AL., ANN RHEUM DIS, (2014), vol. 73, pages 349 - 56 | - |
| DESCRIPTION | - MEASE; ARMSTRONG, DRUGS, (2014), vol. 74, pages 423 - 41 | - |
| DESCRIPTION | - MEASE, CURR OPIN RHEUMATOL., (2013), vol. 25, pages 287 - 96 | - |
| DESCRIPTION | - MEASE ET AL., DRUGS, (2014), vol. 74, pages 423 - 41 | - |
| DESCRIPTION | - MEASE ET AL., N ENGL J MED, (2014), vol. 370, pages 2295 - 306 | - |
| DESCRIPTION | - MENON ET AL., ARTHRITIS RHEUMATOL., (2014), vol. 66, pages 1272 - 81 | - |
| DESCRIPTION | - MENTER ET AL., J AM ACAD DERMATOL, (2011), vol. 65, pages 137 - 74 | - |
| DESCRIPTION | - MEYERS ET AL., COMPUT. APPL. BIOSCI., (1988), vol. 4, page 11 17 | - |
| DESCRIPTION | - MROWIETZ ET AL., ARCH. DERMATOL. RES., (2011), vol. 303, pages 1 - 10 | - |
| DESCRIPTION | - NEEDLEMAN ET AL., J. MOL. BIOL., (1970), vol. 48, page 444 453 | - |
| DESCRIPTION | - NOORDENBOS, ARTHRITIS RHEUM, (2012), vol. 64, pages 99 - 109 | - |
| DESCRIPTION | - "Psoriatic Arthritis", MEASE PJ ET AL., Primer on Rheumatic Diseases. 13th ed., SPRINGER SCIENCE, (2008), pages 170 - 192 | - |
| DESCRIPTION | - SAAD ET AL., ARTHRITIS RES THER, (2009), vol. 11, page R52 | - |
| DESCRIPTION | - TAYLOR ET AL., ARTHRITIS RHEUM, (2006), vol. 38, pages 727 - 35 | - |
| DESCRIPTION | - TAYLOR WET, ARTHRITIS RHEUM, (2006), vol. 54, pages 2665 - 73 | - |
| DESCRIPTION | - VAN DER HEIJDE, ANN. RHEUM. DIS., (2005), vol. 64, pages II61 - II64 | - |
| DESCRIPTION | - VAN DER HEIJDE ET AL., ARTHRITIS RHEUM, (2005), vol. 52, pages 49 - 60 | - |
| DESCRIPTION | - WARD ET AL., NATURE, (1989), vol. 341, pages 544 - 546 | - |
| DESCRIPTION | - WARE ET AL., MED CARE, (1992), vol. 30, pages 473 - 83 | - |
| DESCRIPTION | - WEISMAN ET AL., J DERMATOLOG TREAT., (2003), vol. 14, pages 158 - 65 | - |
| DESCRIPTION | - WELLS ET AL., ANN REHUM DIS, (2009), vol. 68, pages 954 - 60 | - |
| INTERNATIONAL-SEARCH-REPORT | - Alice B. Gottlieb ET AL, "Secukinumab Shows Substantial Improvement In Both Psoriasis Symptoms and Physical Functioning In Moderate-To-Severe Plaque Psoriasis Patients With Psoriatic Arthritis: A Subanalysis Of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study", American Colleage of Rheumatology Meeting Abstracts, (20130101), pages 1 - 4, URL: http://acrabstracts.org/abstract/secukinumab-shows-substantial-improvement-in-both-psoriasis-symptoms-and-physical-functioning-in-moderate-to-severe-plaque-psoriasis-patients-with-psoriatic-arthritis-a-subanalysis-of-a-phase-3-mult/, (20151111), XP055227813 [X] 1,15-17,21-23,28 * abstract * [I] 2-14,18-20,24-27 | - |
| INTERNATIONAL-SEARCH-REPORT | - Rita Baron-Faust, "The IL-17 Superfamily: What Future for PsA? The IL-17 Superfamily: What Future for PsA?", Rheumatology Network, (20140318), pages 1 - 5, URL: http://www.rheumatologynetwork.com/psoriatic-arthritis/il-17-superfamily-what-future-psa, (20151110), XP055227427 [X] 1,7-9,15-17,28 * the whole document * [I] 2-6,10-14,18-27 | - |
| INTERNATIONAL-SEARCH-REPORT | - MCINNES I ET AL, "Anti-Interleukin 17A Monoclonal Antibody Secukinumab Reduces Signs and Symptoms of Psoriatic Arthritis in a 24-Week Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial", ARTHRITIS & RHEUMATISM; 75TH ANNUAL SCIENTIFIC MEETING OF THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY/46TH ANNUAL SCIENTIFIC MEETING, WILEY, US; CHICAGO, IL, USA, vol. 63, no. Suppl. S10, doi:10.1002/ART.33310, ISSN 0004-3591, (20110101), page S306, (20111209), XP008147787 [X] 1,15-17,21,22,28 * abstract * [I] 2-14,18-20,23-27 | |
| INTERNATIONAL-SEARCH-REPORT | - SARAH L. GAFFEN ET AL, "The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing", THE JOURNAL OF IMMUNOLOGY, GB, (20140822), vol. 14, no. 9, doi:10.1038/nri3707, ISSN 1474-1733, pages 585 - 600, XP055227747 [X] 1,15-17,21,22,28 * table 2 * [I] 2-14,18-20,23-27 | |
| INTERNATIONAL-SEARCH-REPORT | - PATEL DHAVALKUMAR D ET AL, "Effect of IL-17A blockade with secukinumab in autoimmune diseases", ANNALS OF THE RHEUMATIC DISEASES, B M J GROUP, GB, (20130401), vol. 72, no. Suppl. 2, ISSN 1468-2060, pages ii116 - ii123, XP009174221 [X] 1,15-17,21,22,28 * the whole document * [I] 2-14,18-20,23-27 | |
| INTERNATIONAL-SEARCH-REPORT | - Alice B Gottlieb ET AL, "AB0738 - Secukinumab Reduces Hscrp Levels in Subjects with Moderate-To-Severe Plaque Psoriasis and Concomitant Psoriatic Arthritis: A Sub-Analysis from the Phase 3 Erasure Study", Annals of the Rheumatic Diseases, doi:10.1136/annrheumdis-2014-eular.1109, (20140101), pages 1 - 1, URL: http://ard.bmj.com/content/73/Suppl_2/1047.2.abstract, (20151111), XP055227757 [X] 1,15-17,21-23,28 * abstract * [I] 2-14,18-20,24-27 | |
| INTERNATIONAL-SEARCH-REPORT | - JOSHUA E WEITZ ET AL, "Ustekinumab: targeting the IL-17 pathway to improve outcomes in psoriatic arthritis", EXPERT OPINION ON BIOLOGICAL THERAPY, ASHLEY, LONDON; GB, (20140401), vol. 14, no. 4, doi:10.1517/14712598.2014.890587, ISSN 1471-2598, pages 515 - 526, XP055226577 [X] 1,7-9,15-17,28 * figure 1; tables 2,3 * [I] 2-6,10-14,18-27 | |
| OPPOSITION | - Alice B. Gottlieb, Bardur Sigurgeirsson, Andrew Blauvelt, Shephard Mpfofu, Ruvie Martin And Charis Papavassilis, "Secukinumab Shows Substantial Improvement In Both Psoriasis Symptoms and Physical Functioning In Moderate-To-Severe Plaque Psoriasis Patients With Psoriatic Arthritis: A Subanalysis Of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study", American Colleage of Rheumatology Meeting Abstracts, pages 1 - 4, American Colleage of Rheumatology Meeting Abstracts, URL: http://acrabstracts.org/abstract/secukinumab-shows-substantial-improvement-in-both-psoriasis-symptoms-and-physical-functioning-in-moderate-to-severe-plaque-psoriasis-patients-with-psoriatic-arthritis-a-subanalysis-of-a-phase-3-mult/, (20151111), XP055227813 | - |
| OPPOSITION | - Anonymous, "Chapter 12 Outcome measures and case definition", Field Trials of Health Interventions: A Toolbox. 3rd edition, OUP Oxford, (20150601), XP093301352 | - |
| OPPOSITION | - Anonymous, "Cosentyx - Summary of Product Characteristics", EMA, (20150101), XP093281199 | - |
| OPPOSITION | - Anonymous, "Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA) (FUTURE 1)", ClinicalTrials.gov; NCT01392326, ClinicalTrials.gov; NCT01392326, URL: https://clinicaltrials.gov/study/NCT01392326?term=NCT01392326&rank=1&a=1&tab=history#version-content-panel, XP093254332 | - |
| OPPOSITION | - Anonymous, "Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA) (FUTURE 1)", ClinicalTrials.gov; NCT01392326, ClinicalTrials.gov; NCT01392326, URL: https://clinicaltrials.gov/study/NCT01392326?term=NCT01392326&rank=1&a=8, XP093254299 | - |
| OPPOSITION | - Anonymous, "Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis (FUTURE 2)", ClinicalTrials.gov; NCT01752634, ClinicalTrials.gov; NCT01752634, URL: https://clinicaltrials.gov/study/NCT01752634?term=NCT01752634&rank=1&a=7, XP093254323 | - |
| OPPOSITION | - Anonymous, "GUIDELINE ON CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF PSORIATIC ARTHRITIS ", EMEA, European Medicines Agency; COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP); Doc. Ref. CHMP/EWP/438/04, EMEA, European Medicines Agency; COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP); Doc. Ref. CHMP/EWP/438/04 , URL: https://www.tga.gov.au/sites/default/files/2024-06/guideline-clinical-investigation-medicinal-products-treatment-psoriatic-arthritis.pdf, XP093254355 | - |
| OPPOSITION | - D38a - Supplementary material of D15 (trial protocol) | - |
| OPPOSITION | - Gottlieb Alice, Langley Richard, Philipp Sandra, Martin Ruvie, Papavassilis Charis, Mpfofu Shephard, "Improvement in Psoriasis Symptoms and Physical Functioning with Secukinumab Compared with Placebo and Etanercept in Subjects with Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis: Results of a Subanalysis from the Phase 3 Fixture Study", 2013 ACR/ARHP Annual Meeting, Abstract L7, 2013 ACR/ARHP Annual Meeting, Abstract L7, URL: https://acrabstracts.org/abstract/improvement-in-psoriasis-symptoms-and-physical-functioning-with-secukinumab-compared-with-placebo-and-etanercept-in-subjects-with-moderate-to-severe-plaque-psoriasis-and-psoriatic-arthritis-results-o/, XP093254302 | - |
| OPPOSITION | - Helliwell Philip, Laura Coates, "Interleukin-17 inhibition in psoriatic arthritis", (20150919), vol. 386, no. 9999, doi:10.1016/S0140-6736(15)60497-4, pages 1114 - 1116, XP093254338 | - |
| OPPOSITION | - Mease Philip J, "Assessment Tools in Psoriatic Arthritis", The Journal of Rheumatology, (20080101), vol. 35, no. 7, pages 1426 - 1430, XP093254361 | - |
| OPPOSITION | - Van Der Heijde Désirée, Landewé Robert B M, Mease Philip J, Mcinnes Iain B, Conaghan Philip G, Pricop Luminita, Ligozio Gregory, Richards Hanno, Mpofu Shephard, "Secukinumab, a Monoclonal Antibody to Interleukin-17A, Provides Signicant and Sustained Inhibition of Joint Structural Damage in Active Psoriatic Arthritis Regardless of Prior TNF Inhibitors or Concomitant Methotrexate: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study", Abstract Number: 954, 2014 ACR/ARHP Annual Meeting, Abstract Number: 954, 2014 ACR/ARHP Annual Meeting , URL: https://acrabstracts.org/abstract/secukinumab-a-monoclonal-antibody-to-interleukin-17a-provides-significant-and-sustained-inhibition-of-joint-structural-damage-in-active-psoriatic-arthritis-regardless-of-prior-tnf-inhibitors-or-conc/, XP093254374 | - |
| OPPOSITION | - David T. Felson, Jennifer J. Anderson, Maarten Boers, Claire Bombardier, Daniel Furst, Charles Goldsmith, Linda M. Katz, Robert Lightfoot, Harold Paulus, Vibeke Strand, Peter Tugwell, Michael Weinblatt, H. James Williams, Frederick Wolfe, Stephanie Kieszak, "American college of rheumatology preliminary definition of improvement in rheumatoid arthritis", Arthritis & Rheumatism, J.B. Lippincott Co., (19950601), vol. 38, no. 6, doi:10.1002/art.1780380602, ISSN 00043591, pages 727 - 735, XP055047068 | |
| OPPOSITION | - Heijde Désirée Van, Landewé Robert, Klareskog Lars, Rodríguez‐valverde Vicente, Settas Lucas, Pedersen Ronald, Fatenejad Saeed, "Presentation and analysis of data on radiographic outcome in clinical trials: Experience from the TEMPO study", Arthritis & Rheumatism, Wiley InterScience, US, US , (20050101), vol. 52, no. 1, doi:10.1002/art.20775, ISSN 0004-3591, pages 49 - 60, XP093254382 | |
| OPPOSITION | - Van Der Heijde, Kavanaugh A., Gladman D. D., Antoni C., Krueger G. G., Guzzo C., Zhou B., Dooley L. T., De Vlam K., Geusens P., Birbara C., Halter D., Beutler A., "Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2", Arthritis & Rheumatism, Wiley InterScience, US, US , (20070801), vol. 56, no. 8, doi:10.1002/art.22805, ISSN 0004-3591, pages 2698 - 2707, XP093254376 | |
| OPPOSITION | - Kavanaugh Arthur, Van Der Heijde Désirée, Mcinnes Iain B., Mease Philip, Krueger Gerald G., Gladman Dafna D., Gómez‐reino Juan, Papp Kim, Baratelle Anna, Xu Weichun, Mudivarthy Surekha, Mack Michael, Rahman Mahboob U., Xu Zhenhua, Zrubek Julie, Beutler Anna, "Golimumab in psoriatic arthritis: One‐year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo‐controlled trial", Arthritis & Rheumatism, Wiley InterScience, US, US , (20120801), vol. 64, no. 8, doi:10.1002/art.34436, ISSN 0004-3591, pages 2504 - 2517, XP093254377 | |
| OPPOSITION | - Bina Menon; Nicola J. Gullick; Gina J. Walter; Megha Rajasekhar; Toby Garrood; Hayley G. Evans; Leonie S. Taams; Bruce W. Kirkham, "Interleukin‐17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression", Arthritis & Rheumatology, John Wiley & Sons, Inc., US, US , (20140428), vol. 66, no. 5, doi:10.1002/art.38376, ISSN 2326-5191, pages 1272 - 1281, XP072275342 | |
| OPPOSITION | - Marinoni Beatrice; Ceribelli Angela; Massarotti Marco S.; Selmi Carlo, "The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications", Autoimmunity Highlights, Springer International Publishing, Cham, Cham , (20140122), vol. 5, no. 1, doi:10.1007/s13317-013-0057-4, ISSN 2038-0305, pages 9 - 19, XP035980848 | |
| OPPOSITION | - Gisondi Paolo, Dalle Vedove Camilla, Girolomoni Giampiero, "Efficacy and Safety of Secukinumab in Chronic Plaque Psoriasis and Psoriatic Arthritis Therapy", Dermatology and Therapy, (20140601), vol. 4, no. 1, doi:10.1007/s13555-014-0042-5, ISSN 2193-8210, pages 1 - 9, XP093254308 | |
| OPPOSITION | - Philip J. Mease, Armstrong April W., "Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis", Drugs, Adis International Ltd., NZ, NZ , (20140301), vol. 74, no. 4, doi:10.1007/s40265-014-0191-y, ISSN 0012-6667, pages 423 - 441, XP055411681 | |
| OPPOSITION | - Suzuki Erika, Mellins Elizabeth D., Gershwin M. Eric, Nestle Frank O., Adamopoulos Iannis E., "The IL-23/IL-17 axis in psoriatic arthritis", AUTOIMMUNITY REVIEWS, ELSEVIER, AMSTERDAM, NL, NL , (20140401), vol. 13, no. 4-5, doi:10.1016/j.autrev.2014.01.050, ISSN 1568-9972, pages 496 - 502, XP093254313 | |
| OPPOSITION | - Gottlieb, A. ; Korman, N.J. ; Gordon, K.B. ; Feldman, S.R. ; Lebwohl, M. ; Koo, J.Y.M. ; Van Voorhees, A.S. ; Elmets, C.A. ; Leonardi, C.L. ; Beutner, K.R. ; Bhushan, R. ; Menter, A., "Guidelines of care for the management of psoriasis and psoriatic arthritis", Journal of the American Academy of Dermatology, Mosby, Inc, US, US , (20080501), vol. 58, no. 5, doi:10.1016/j.jaad.2008.02.040, ISSN 0190-9622, pages 851 - 864, XP022609137 | |
| OPPOSITION | - Mcinnes Iain B, Kavanaugh Arthur, Gottlieb Alice B, Puig Lluís, Rahman Proton, Ritchlin Christopher, Brodmerkel Carrie, Li Shu, Wang Yuhua, Mendelsohn Alan M, Doyle Mittie K, "Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial", The Lancet, (20130801), vol. 382, no. 9894, doi:10.1016/S0140-6736(13)60594-2, ISSN 0140-6736, pages 780 - 789, XP093254379 | |
| OPPOSITION | - Mcinnes Iain B, Mease Philip J, Kirkham Bruce, Kavanaugh Arthur, Ritchlin Christopher T, Rahman Proton, Van Der Heijde Désirée, Landewé Robert, Conaghan Philip G, Gottlieb Alice B, Richards Hanno, Pricop Luminita, Ligozio Gregory, Patekar Manmath, Mpofu Shephard, "Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial", The Lancet, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20150901), vol. 386, no. 9999, doi:10.1016/S0140-6736(15)61134-5, ISSN 0140-6736, pages 1137 - 1146, XP055816435 | |
| OPPOSITION | - H Huang, H J Kim, E-J Chang, Z H Lee, S J Hwang, H-M Kim, Y Lee, H-H Kim, "IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling", Cell Death & Differentiation, Nature Publishing Group, GB, GB , (20091019), vol. 16, no. 10, doi:10.1038/cdd.2009.74, ISSN 1350-9047, pages 1332 - 1343, XP055259952 | |
| OPPOSITION | - Richard G. Langley, Boni E. Elewski, Mark Lebwohl, Kristian Reich, Christopher E.M. Griffiths, Kim Papp, Lluís Puig, Hidemi Nakagawa, Lynda Spelman, Bárður Sigurgeirsson, Enrique Rivas, Tsen-Fang Tsai, Norman Wasel, Stephen Tyring, Thomas Salko, Isabelle Hampele, Marianne Notter, Alexander Karpov, Silvia Helou, Charis Papavassilis, "Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials", The New England journal of medicine, Massachusetts Medical Society, US, US , (20140724), vol. 371, no. 4, doi:10.1056/NEJMoa1314258, ISSN 0028-4793, pages 326 - 338, XP055414280 | |
| OPPOSITION | - Li Guowei, Taljaard Monica, Van Den Heuvel Edwin R., Levine Mitchell Ah., Cook Deborah J., Wells George A., Devereaux Philip J., Thabane Lehana, "An introduction to multiplicity issues in clinical trials: the what, why, when and how", INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, Oxford University Press, GB, GB , doi:10.1093/ije/dyw320, ISSN 0300-5771, page dyw320, XP093301354 | |
| OPPOSITION | - Bruce W. Kirkham, Arthur Kavanaugh, Kristian Reich, "Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis", Cancer research, Wiley-Blackwell Publishing Ltd., GB, GB , (20140209), vol. 141, no. 2, doi:10.1111/imm.12142, ISSN 0019-2805, pages 133 - 142, XP055303103 | |
| OPPOSITION | - L Gossec, J S Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, D van der Heijde, O FitzGerald, D Aletaha, P Balint, D Boumpas, J Braun, F C Breedveld, G Burmester, J D Cañete, M de Wit, H Dagfinrud, K de Vlam, M Dougados, P Helliwell, A Kavanaugh, P Emery, "European League against rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies", Annals of the Rheumatic Diseases, B M J Group, GB, GB , (20120101), vol. 71, no. 1, doi:10.1136/annrheumdis-2011-200350, ISSN 1468-2060, pages 4 - 12, XP009559720 | |
| OPPOSITION | - Patel Dhavalkumar D; Lee David M; Kolbinger Frank; Antoni Christian, "Effect of IL-17A blockade with secukinumab in autoimmune diseases.", Annals of the Rheumatic Diseases, B M J Group, GB, GB , (20130401), vol. 72, no. Suppl. 2, doi:10.1136/annrheumdis-2012-202371, ISSN 1468-2060, pages ii116 - ii123, XP009174221 | |
| OPPOSITION | - Mcinnes Iain B, Sieper Joachim, Braun Jürgen, Emery Paul, Van Der Heijde Désirée, Isaacs John D, Dahmen Georg, Wollenhaupt Jürgen, Schulze-Koops Hendrik, Kogan Joseph, Ma Shenglin, Schumacher Martin M, Bertolino Arthur P, Hueber Wolfgang, Tak Paul P, "Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial", Annals of the Rheumatic Diseases, (20140201), vol. 73, no. 2, doi:10.1136/annrheumdis-2012-202646, ISSN 0003-4967, pages 349 - 356, XP009559708 | |
| OPPOSITION | - Kavanaugh A, Ritchlin C, Rahman P, Puig L, Gottlieb AB, Li S, Wang Y, Noonan L, Brodmerkel C,, "Ustekinumab, an anti- IL -12/23 p40 monoclonal antibody, inhibits 1 radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials", Annals of the Rheumatic Diseases, (20140219), vol. 73, no. 6, doi:10.1136/annrheumdis-2013-204741, ISSN 0003-4967, pages 1000 - 1006, XP009514326 | |
| OPPOSITION | - Alice B Gottlieb, B. Sigurgeirsson, A. Blauvelt, Y. Gong, C. Papavassilis, S. Mpofu, "AB0738 Secukinumab Reduces Hscrp Levels in Subjects with Moderate-To-Severe Plaque Psoriasis and Concomitant Psoriatic Arthritis: A Sub-Analysis from the Phase 3 Erasure Study", Annals of the Rheumatic Diseases, doi:10.1136/annrheumdis-2014-eular.1109, pages 1 - 1, Annals of the Rheumatic Diseases, URL: http://ard.bmj.com/content/73/Suppl_2/1047.2.abstract, (20151111), XP055227757 | |
| OPPOSITION | - S. Ramiro, J.S. Smolen, R. Landewé, D. van der Heijde, M. Dougados, P. Emery, M. De Wit, M. Cutolo, S. Oliver, L. Gossec, "THU0412 Pharmacological Treatment of Psoriatic Arthritis (PSA): Systematic Literature Review for the Update of the Eular Recommendations for the Management of PSA", Annals of the Rheumatic Diseases; Poster Presentations - Psoriatic arthritis, (20150101), vol. 74, no. 2, doi:10.1136/annrheumdis-2015-eular.4236, page 346, XP009559709 | |
| OPPOSITION | - Van Der Heijde, Sharp J, Wassenberg S, Gladman D D, "Psoriatic arthritis imaging: a review of scoring methods", Annals of the Rheumatic Diseases, (20050301), vol. 64, doi:10.1136/ard.2004.030809, ISSN 0003-4967, pages ii61 - ii64, XP093254330 | |
| OPPOSITION | - Antoni C, Krueger G G, De Vlam K, Birbara C, Beutler A, Guzzo C, Zhou B, Dooley L T, Kavanaugh A, "Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial", Annals of the Rheumatic Diseases, BMJ Publishing Group Ltd and European League Against Rheumatism, London, London, (20050801), vol. 64, no. 8, doi:10.1136/ard.2004.032268, ISSN 0003-4967, pages 1150 - 1157, XP009559762 | |
| OPPOSITION | - Ory P A, Gladman D D, Mease P J, "Psoriatic arthritis and imaging", Annals of the Rheumatic Diseases, (20050301), vol. 64, doi:10.1136/ard.2004.033928, ISSN 0003-4967, pages ii55 - ii57, XP093254359 | |
| OPPOSITION | - Mease P J, Ory P, Sharp J T, Ritchlin C T, Van Den Bosch F, Wellborne F, Birbara C, Thomson G T D, Perdok R J, Medich J, Wong R L, Gladman D D, "Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)", Annals of the Rheumatic Diseases, (20090501), vol. 68, no. 5, doi:10.1136/ard.2008.092767, ISSN 0003-4967, pages 702 - 709, XP093254388 | |
| OPPOSITION | - Schett Georg, Coates Laura C, Ash Zoe R, Finzel Stefanie, Conaghan Phillip G, "Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future", ARTHRITIS RESEARCH AND THERAPY, BIOMED CENTRAL, LONDON, GB, GB , (20111201), vol. 13, no. S1, doi:10.1186/1478-6354-13-S1-S4, ISSN 1478-6354, XP093254311 | |
| OPPOSITION | - Combe Bernard, "Update on the use of etanercept across a spectrum of rheumatoid disorders", Biologics: Targets and Therapy, Dove Medical Press, NZ, NZ , doi:10.2147/BTT.S1379, ISSN 1177-5475, page 165, XP093254386 | |
| OPPOSITION | - Fitzgerald Oliver, Ritchlin Christopher T., Mease Philip J., "Biomarkers of Radiographic Progression in Psoriatic Arthritis: A Report from the GRAPPA 2011 Annual Meeting", JOURNAL OF RHEUMATOLOGY, Journal of Rheumatology Publishing Company., CA, CA , (20121101), vol. 39, no. 11, doi:10.3899/jrheum.120820, ISSN 0315-162X, pages 2189 - 2192, XP093254365 | |
